Elevance (ELV) PT Lowered to $478 at RBC Capital

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. PEP
5. CVS
6. T
7. UNH
8. SBUX
9. AXP
10. RTX

Go back to Elevance (ELV) PT Lowered to $478 at RBC Capital

Elevance Health Reports Third Quarter 2024 Results

October 17, 2024 6:00 AM EDT

3Q 2024 operating revenue of $44.7 billion 3Q 2024 adjusted operating gain1 of $2.4 billion 3Q 2024 diluted EPS2 of $4.36; adjusted diluted EPS1 of $8.37 4Q 2024 dividend of $1.63 per share declared to shareholders

INDIANAPOLIS--(BUSINESS WIRE)-- Elevance Health, Inc. (NYSE: ELV) reported third quarter 2024 results.

We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating environment and unprecedented challenges in the Medicaid business. We expect Medicaid rates will align with the needs of our members in time,... More